Canada approves new drug that can slow Alzheimer’s disease
For the first time, Health Canada has approved a new drug that targets the underlying cause of early-onset Alzheimer’s to slow its progression. Credit to: Global News
For the first time, Health Canada has approved a new drug that targets the underlying cause of early-onset Alzheimer’s to slow its progression. Credit to: Global News